ResearcherCentre Hospitalier Universitaire de ReimsNo recent work listed

Q. Laurent-Badr

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5041219619. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1016/j.dld.2020.03.014 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cindy Neuzillet · 1 shared paper, 2020 · strength 0.09
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014 ↗
Mathias Brügel · 1 shared paper, 2020 · strength 0.09
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014 ↗
Sophie Deguelte · 1 shared paper, 2020 · strength 0.09
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014 ↗
Louis de Mestier · 1 shared paper, 2020 · strength 0.09
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014 ↗
Olivier Bouché · 1 shared paper, 2020 · strength 0.09
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.